Shattuck Labs Inc
NASDAQ:STTK

Watchlist Manager
Shattuck Labs Inc Logo
Shattuck Labs Inc
NASDAQ:STTK
Watchlist
Price: 1.05 USD 1.45% Market Closed
Market Cap: 50.3m USD

Relative Value

The Relative Value of one STTK stock under the Base Case scenario is 0.66 USD. Compared to the current market price of 1.05 USD, Shattuck Labs Inc is Overvalued by 37%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

STTK Relative Value
Base Case
0.66 USD
Overvaluation 37%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
53
vs Industry
45
Median 3Y
43.6
Median 5Y
11.6
Industry
7
vs History
vs Industry
Median 3Y
-1.4
Median 5Y
-2.2
Industry
22.7
Forward
-1
vs History
vs Industry
Median 3Y
-1.3
Median 5Y
-2.2
Industry
19.4
vs History
vs Industry
Median 3Y
-1.2
Median 5Y
-1.9
Industry
22.6
vs History
62
vs Industry
68
Median 3Y
0.7
Median 5Y
0.9
Industry
2.6
vs History
vs Industry
22
Median 3Y
-2.4
Median 5Y
-2.5
Industry
7.3
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
9.4
vs History
51
vs Industry
24
Median 3Y
0.2
Median 5Y
0.2
Industry
4.6
Forward
0.2
vs History
37
vs Industry
23
Median 3Y
0.2
Median 5Y
-0.1
Industry
4.5
Forward
0.2
vs History
37
vs Industry
26
Median 3Y
0.2
Median 5Y
-0
Industry
5
vs History
37
vs Industry
21
Median 3Y
0.2
Median 5Y
-0
Industry
3.7
vs History
vs Industry
39
Median 3Y
-0.6
Median 5Y
0
Industry
4.9

Multiples Across Competitors

STTK Competitors Multiples
Shattuck Labs Inc Competitors

Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Shattuck Labs Inc
NASDAQ:STTK
50.3m USD 10.9 -0.7 0.1 0.1
FR
Pharnext SCA
OTC:PNEXF
6T USD 33 948 782 -161 353.5 -195 934.6 -193 698.8
US
Abbvie Inc
NYSE:ABBV
329.9B USD 5.8 79.4 15.1 22.4
US
Amgen Inc
NASDAQ:AMGN
149.7B USD 4.4 25.2 13.7 22.6
US
Gilead Sciences Inc
NASDAQ:GILD
134B USD 4.7 22.5 9.8 13.5
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
113.8B USD 10.3 -115.2 24.4 25.6
US
Epizyme Inc
F:EPE
94.1B EUR 2 075.2 -529.5 -576.6 -561.2
AU
CSL Ltd
ASX:CSL
116.2B AUD 5 27.6 17 21.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
56.4B USD 4 12.5 11.1 12.5
US
Seagen Inc
F:SGT
39.3B EUR 20 -61.3 -66.1 -59.6
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
41.4B USD 17.6 -153.6 -688.7 -345.1
P/E Multiple
Earnings Growth PEG
US
Shattuck Labs Inc
NASDAQ:STTK
Average P/E: 33.4
Negative Multiple: -0.7
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -161 353.5 N/A N/A
US
Abbvie Inc
NYSE:ABBV
79.4
88%
0.9
US
Amgen Inc
NASDAQ:AMGN
25.2
45%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
22.5
188%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -115.2 N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -529.5 N/A N/A
AU
CSL Ltd
ASX:CSL
27.6
16%
1.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
12.5
7%
1.8
US
S
Seagen Inc
F:SGT
Negative Multiple: -61.3 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -153.6 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Shattuck Labs Inc
NASDAQ:STTK
Average EV/EBITDA: 13.1
0.1
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -195 934.6 N/A N/A
US
Abbvie Inc
NYSE:ABBV
15.1
13%
1.2
US
Amgen Inc
NASDAQ:AMGN
13.7
17%
0.8
US
Gilead Sciences Inc
NASDAQ:GILD
9.8
6%
1.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24.4
17%
1.4
US
E
Epizyme Inc
F:EPE
Negative Multiple: -576.6 N/A N/A
AU
CSL Ltd
ASX:CSL
17
11%
1.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
11.1
11%
1
US
S
Seagen Inc
F:SGT
Negative Multiple: -66.1 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -688.7 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Shattuck Labs Inc
NASDAQ:STTK
Average EV/EBIT: 16.9
0.1
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -193 698.8 N/A N/A
US
Abbvie Inc
NYSE:ABBV
22.4
29%
0.8
US
Amgen Inc
NASDAQ:AMGN
22.6
32%
0.7
US
Gilead Sciences Inc
NASDAQ:GILD
13.5
11%
1.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
25.6
17%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -561.2 N/A N/A
AU
CSL Ltd
ASX:CSL
21.3
14%
1.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
12.5
11%
1.1
US
S
Seagen Inc
F:SGT
Negative Multiple: -59.6 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -345.1 N/A N/A